Amedisys, Inc. (AMED)
After hours:
| Previous Close | 91.16 |
| Open | 90.98 |
| Bid | 83.61 x 200 |
| Ask | 98.59 x 200 |
| Day's Range | 90.80 - 91.15 |
| 52 Week Range | 73.10 - 96.44 |
| Volume | |
| Avg. Volume | 279,574 |
| Market Cap | 2.98B |
| Beta (5Y Monthly) | 0.86 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.30 |
| Earnings Date | Jul 24, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 97.78 |
ZacksCompared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
ZacksAmedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
Amedisys (AMED) delivered earnings and revenue surprises of 1.98% and 1.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireAmedisys Reports First Quarter 2024 Financial Results
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024. Three-Month Periods Ended March 31, 2024 and 2023 Net service revenue increased $15.0 million to $571.4 million compared to $556.4 million in 2023. Prior year included $15.0 million of net service revenue from our personal care business which was divested on March 31, 2023.Net income attributable to Amedisys, Inc. of $14.4 millio
